Zobrazeno 1 - 10
of 16
pro vyhledávání: '"R A A Mathôt"'
Autor:
K. J. Ploegmakers, E. P. vanPoelgeest, L. J. Seppala, S. C. vanDijk, L. C. P. G. M. deGroot, S. Oliai Araghi, N. M. vanSchoor, B. Stricker, K. M. A. Swart, A. G. Uitterlinden, R. A. A. Mathôt, N. van derVelde
Publikováno v:
Pharmacology Research & Perspectives, Vol 11, Iss 6, Pp n/a-n/a (2023)
Abstract Beta‐blocker usage is inconsistently associated with increased fall risk in the literature. However, due to age‐related changes and interindividual heterogeneity in pharmacokinetics and dynamics, it is difficult to predict which older ad
Externí odkaz:
https://doaj.org/article/f94491d99d824e60b98b9da9e0824286
Autor:
A. C. Pronk, E. P. van Poelgeest, L. J. Seppala, K. J. Ploegmakers, B. H. Stricker, K. M. A. Swart, S. C. van Dijk, S. Oliai Araghi, L. C. P. G. M. de Groot, N. M. van Schoor, R. A. A. Mathôt, N. van der Velde
Publikováno v:
European Geriatric Medicine, 14(1), 89-97. Elsevier Masson
Pronk, A C, van Poelgeest, E P, Seppala, L J, Ploegmakers, K J, Stricker, B H, Swart, K M A, van Dijk, S C, Oliai Araghi, S, de Groot, L C P G M, van Schoor, N M, Math?t, R A A & van der Velde, N 2023, ' Are higher antidepressant plasma concentrations associated with fall risk in older antidepressant users? ', European Geriatric Medicine, vol. 14, no. 1, pp. 89-97 . https://doi.org/10.1007/s41999-022-00742-1
European Geriatric Medicine 14 (2023) 1
European Geriatric Medicine, 14(1), 89-97
European geriatric medicine, 14(1), 89-97. Elsevier Masson
Pronk, A C, van Poelgeest, E P, Seppala, L J, Ploegmakers, K J, Stricker, B H, Swart, K M A, van Dijk, S C, Oliai Araghi, S, de Groot, L C P G M, van Schoor, N M, Math?t, R A A & van der Velde, N 2023, ' Are higher antidepressant plasma concentrations associated with fall risk in older antidepressant users? ', European Geriatric Medicine, vol. 14, no. 1, pp. 89-97 . https://doi.org/10.1007/s41999-022-00742-1
European Geriatric Medicine 14 (2023) 1
European Geriatric Medicine, 14(1), 89-97
European geriatric medicine, 14(1), 89-97. Elsevier Masson
Purpose Antidepressants are well-established fall-risk increasing drugs (FRIDs) and therefore falls should be considered an important adverse drug event (ADE) of antidepressants. However, not all antidepressant users experience fall incidents and fac
Autor:
K P van Rhee, S L de Vroom, R M van Hest, P D van der Linden, S H Tonino, E Molendijk, R A A Mathôt, N M A Blijlevens, C A J Knibbe, R J M Bruggemann, S E Geerlings
Publikováno v:
Journal of Antimicrobial Chemotherapy, 77, 11, pp. 3069-3076
The Journal of antimicrobial chemotherapy, 77(11), 3069-3076. Oxford University Press
Journal of Antimicrobial Chemotherapy, 77, 3069-3076
Journal of Antimicrobial Chemotherapy, 77(11), 3069-3076. OXFORD UNIV PRESS
The Journal of antimicrobial chemotherapy, 77(11), 3069-3076. Oxford University Press
Journal of Antimicrobial Chemotherapy, 77, 3069-3076
Journal of Antimicrobial Chemotherapy, 77(11), 3069-3076. OXFORD UNIV PRESS
Background Patients with haematological malignancies frequently endure neutropenia and gastrointestinal (GI)-mucositis after high-dose chemotherapy. In these patients, ciprofloxacin is used for Gram-negative infection prophylaxis. Objectives We inves
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::37334b498f4033149b8f929dcbaa33cb
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/287859
https://hdl.handle.net/https://repository.ubn.ru.nl/handle/2066/287859
Autor:
Hendrika C A M Hazendonk, Tim Preijers, Frank W.G. Leebeek, R. A. A. Mathôt, Felix J. M. van der Meer, Iris van Moort, Britta A P Laros-van Gorkom, Marjon H. Cnossen, Laurens Nieuwenhuizen, Karina Meijer, Karin Fijnvandraat, Roger E. G. Schutgens
Publikováno v:
British Journal of Clinical Pharmacology, 87(6), 2602-2613. Wiley
British Journal of Clinical Pharmacology, 87, 2602-2613
British Journal of Clinical Pharmacology, 87(6), 2602-2613. Wiley-Blackwell Publishing Ltd
British journal of clinical pharmacology, 87(6), 2602-2613. Wiley-Blackwell
British Journal of Clinical Pharmacology, 87, 6, pp. 2602-2613
British Journal of Clinical Pharmacology
British Journal of Clinical Pharmacology, 87, 2602-2613
British Journal of Clinical Pharmacology, 87(6), 2602-2613. Wiley-Blackwell Publishing Ltd
British journal of clinical pharmacology, 87(6), 2602-2613. Wiley-Blackwell
British Journal of Clinical Pharmacology, 87, 6, pp. 2602-2613
British Journal of Clinical Pharmacology
Contains fulltext : 245042.pdf (Publisher’s version ) (Open Access) AIMS: Under- and, especially, overdosing of replacement therapy in haemophilia A patients may be prevented by application of other morphometric variables than body weight (BW) to d
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::45ce2ecb1ea7f2d1442bad3d0e357fda
https://research.rug.nl/en/publications/b785c50f-97d8-4f39-b173-ebc413b6381b
https://research.rug.nl/en/publications/b785c50f-97d8-4f39-b173-ebc413b6381b
Autor:
Reinier M. van Hest, R. A. A. Mathôt, Tim Preijers, Lisette M. Schütte, Marjon H. Cnossen, Marieke J. H. A. Kruip, Frank W.G. Leebeek
Publikováno v:
Therapeutic Drug Monitoring, 41(2), 192-212. Lippincott Williams & Wilkins
Hemophilia A and hemophilia B are hereditary bleeding disorders, caused by a deficiency of clotting factor VIII or clotting factor IX, respectively. To treat and prevent bleedings, patients can administer clotting factor concentrates (hemophilia A an
Autor:
Marjon H. Cnossen, R. A. A. Mathôt, Tim Preijers, Lisette M. Schütte, Marieke J. H. A. Kruip, Reinier M. van Hest, Frank W.G. Leebeek
Publikováno v:
Clinical Pharmacokinetics, 60(1). Adis
Clinical Pharmacokinetics
Clinical Pharmacokinetics
Hemophilia A and B are bleeding disorders caused by a deficiency of clotting factor VIII and IX, respectively. Patients with severe hemophilia (
Autor:
Sebastiaan Sassen, R. A. A. Mathôt, Rob Pieters, V. de Haas, G. J .L. Kaspers, C. van den Bos, Wim J. E. Tissing, D. M. W. W. te Loo, M. B. Bierings, I. M. van der Sluis, C. Michel Zwaan
Publikováno v:
SSRN Electronic Journal.
Autor:
R. A. A. Mathôt, I. van Moort, Karin Fijnvandraat, Frank W.G. Leebeek, Tim Preijers, Marjon H. Cnossen
Publikováno v:
Thrombosis and Haemostasis, 118(3), 514-525. Georg Thieme Verlag
Thrombosis and haemostasis, 118(3), 514-525. Schattauer GmbH
Thrombosis and haemostasis, 118(3), 514-525. Schattauer GmbH
Background Patients with severe and moderate haemophilia A are treated prophylactically with factor VIII (FVIII) concentrate. Individualization of prophylaxis can be achieved by pharmacokinetic (PK)-guided dosing. Aim In this study, the performance o
Autor:
R. A. A. Mathôt, Hendrika C A M Hazendonk, Karin Fijnvandraat, Frank W.G. Leebeek, Tim Preijers, Marjon H. Cnossen
Publikováno v:
Journal of Thrombosis and Haemostasis, 15(9), 1737-1746. Wiley-Blackwell Publishing Ltd
Journal of thrombosis and haemostasis, 15(9), 1737-1746. Wiley-Blackwell
Journal of thrombosis and haemostasis, 15(9), 1737-1746. Wiley-Blackwell
Essentials Individual pharmacokinetic (PK) parameters can be obtained by limited sampling strategies (LSSs). Following 100 IU kg−1 rFIX, LSSs with 1 to 3 samples were evaluated in 5000 simulated subjects. For all LSSs, estimated individual PK param
Autor:
H C A M, Hazendonk, J M, Heijdra, N C B, de Jager, H C, Veerman, J, Boender, I, van Moort, R A A, Mathôt, K, Meijer, B A P, Laros-van Gorkom, J, Eikenboom, K, Fijnvandraat, F W G, Leebeek, M H, Cnossen
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia. 24(3)
Patients with Von Willebrand disease (VWD) are regularly treated with VWF-containing concentrates in case of acute bleeding, trauma and dental or surgical procedures.In this multicentre retrospective study, current perioperative management with a von